loadpatents
name:-0.021225929260254
name:-0.011500835418701
name:-0.00042319297790527
Swinamer; Alan David Patent Filings

Swinamer; Alan David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Swinamer; Alan David.The latest application filed is for "pyridinyl compounds useful as intermediates".

Company Profile
0.12.17
  • Swinamer; Alan David - Southbury CT
  • Swinamer; Alan David - Woodbury CT
  • Swinamer; Alan David - Bethel CT
  • Swinamer; Alan David - Ridgefield CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CCR10 antagonists
Grant 8,299,123 - Dey , et al. October 30, 2
2012-10-30
Indazole compounds as CCR1 receptor antagonists
Grant 8,263,597 - Kuzmich , et al. September 11, 2
2012-09-11
Pyridinyl Compounds Useful As Intermediates
App 20120136158 - COOK; Brian Nicholas ;   et al.
2012-05-31
Azaindazole Compounds As CCR1 Receptor Antagonists
App 20120035370 - COOK; Brian Nicholas ;   et al.
2012-02-09
Indazole Compounds As CCR1 Receptor Antagonists
App 20110294808 - KUZMICH; Daniel ;   et al.
2011-12-01
Azaindazole compounds as CCR1 receptor antagonists
Grant 8,063,065 - Cook , et al. November 22, 2
2011-11-22
Pyrazole Compounds As CCR1 Antagonists
App 20110230521 - Cook; Brian Nicholas ;   et al.
2011-09-22
Indazole compounds as CCR1 receptor antagonists
Grant 8,008,327 - DiSalvo , et al. August 30, 2
2011-08-30
Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors
App 20110118262 - Bentzien; Joerg Martin ;   et al.
2011-05-19
Azaindazole Compounds As CCR1 Receptor Antagonists
App 20110086846 - COOK; Brian Nicholas ;   et al.
2011-04-14
Ccr10 Antagonists
App 20110039851 - Dey; Kaka ;   et al.
2011-02-17
Indazole Compounds As CCR1 Receptor Antagonists
App 20110034512 - Disalvo; Darren ;   et al.
2011-02-10
Azaindazole compounds as CCR1 receptor antagonists
Grant 7,879,873 - Cook , et al. February 1, 2
2011-02-01
Azaindazole Compounds As CCR1 Receptor Antagonists
App 20100093724 - COOK; Brian Nicholas ;   et al.
2010-04-15
Cytokine inhibitors
Grant 7,569,568 - Cogan , et al. August 4, 2
2009-08-04
Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
Grant 7,550,461 - Gao , et al. June 23, 2
2009-06-23
Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same
App 20090111791 - De Lombaert; Stephane ;   et al.
2009-04-30
Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
App 20090099184 - Delombaert; Stephane ;   et al.
2009-04-16
Anti-cytokine heterocyclic compounds
Grant 7,514,458 - Cogan , et al. April 7, 2
2009-04-07
Anti-cytokine heterocyclic compounds
Grant 7,485,657 - Cogan , et al. February 3, 2
2009-02-03
Anti-Cytokine Heterocyclic Compounds
App 20070142371 - Cogan; Derek ;   et al.
2007-06-21
Anti-cytokine heterocyclic compounds
Grant 7,214,802 - Cogan , et al. May 8, 2
2007-05-08
Cytokine Inhibitors
App 20070032492 - Cogan; Derek A. ;   et al.
2007-02-08
Cytokine inhibitors
Grant 7,166,628 - Cogan , et al. January 23, 2
2007-01-23
Anti-cytokine heterocyclic compounds
App 20060079519 - Cogan; Derek ;   et al.
2006-04-13
Anti-cytokine heterocyclic compounds
App 20050256113 - Cogan, Derek ;   et al.
2005-11-17
Cytokine inhibitors
App 20040102492 - Cogan, Derek A. ;   et al.
2004-05-27
Compounds useful in treating cytokine mediated diseases
App 20030225053 - Gao, Donghong Amy ;   et al.
2003-12-04
Aromatic heterocyclic compounds as antiinflammatory agents
Grant 6,525,046 - Cirillo , et al. February 25, 2
2003-02-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed